Movement Alert|Synopsys Rises 4% in Regular Trading, Multiple Investment Banks Upgrade Ratings Forming Bullish Consensus

Market Focus
Sep 25

On September 25, Synopsys rose 4% in regular trading, trading at approximately $442.42 per share, with turnover of $48.81 million.

On the news front, BNP Paribas upgraded Synopsys from underperform to neutral with a price target of $420, the latest in a series of bullish analyst actions. Earlier, Morgan Stanley had upgraded the stock to overweight with a $500 price target, while Baird raised its rating to outperform with a $560 target. The convergence of multiple upgrades has formed a strong bullish resonance, significantly easing market concerns about AI disrupting the traditional EDA industry.

On the fundamental side, Synopsys reported fiscal Q3 revenue of $2.48 billion, up 42% year-over-year, with adjusted EPS of $3.91, both exceeding consensus estimates. The company also raised its full-year revenue guidance to $9.69 billion to $9.74 billion. Management emphasized that EDA growth is accelerating toward double digits, and design IP has returned to a growth trajectory, with Ansys integration synergies beginning to materialize.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10